Letter| Volume 21, ISSUE 5, P916, May 1999


      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Knapp M
        • Kavanagh S
        Economic outcomes and costs in the treatment of schizophrenia.
        Clin Ther. 1997; 19: 128-138
        • Rupp A
        • Gause EM
        • Regier DA
        Research policy implications of cost-of-illness studies for mental disorders.
        Br J Psychiatry Suppl. 1998; 36: 19-25